1. Lipoprotein Metabolism

   • James Shepherd

   OriginalPaper 18 October 2012 Pages: 1 - 10

2. Analysis of Angiographic Trial Data in Women

   • Richard J. Havel

   OriginalPaper 18 October 2012 Pages: 11 - 15

3. Postmenopausal Hormone Replacement Therapy and Cardiovascular Risk Reduction

   • Stephanie D. Kafonek

   OriginalPaper 18 October 2012 Pages: 16 - 24

4. Postmenopausal Hormone Replacement Therapy, Coronary Heart Disease and Plasma Lipoproteins

   • Mary Seed

   OriginalPaper 18 October 2012 Pages: 25 - 34

5. Hormone Replacement Therapy and the Cardiovascular System

   • John C. Stevenson
   • David Crook
   • Malcolm I. Whitehead

   OriginalPaper 18 October 2012 Pages: 35 - 41

6. Effects of Estrogen Treatment on Arterial Wall Structure and Function

   • Thomas B. Clarkson
   • Mary S. Anthony
   • Karen Potvin Klein

   OriginalPaper 18 October 2012 Pages: 42 - 51

7. Discussion: Sections 1 and 2

   OriginalPaper 18 October 2012 Pages: 52 - 53

8. Gender-Related Response to Fluvastatin in Patients with Heterozygous Familial Hypercholesterolaemia

   • Eran Leitersdorf

   OriginalPaper 18 October 2012 Pages: 54 - 58

9. Efficacy and Safety of Fluvastatin, a New HMG CoA Reductase Inhibitor, in Elderly Hypercholesterolaemic Women

   • G. Baggio
   • O. De Candia
   • G. Crepaldi

   OriginalPaper 18 October 2012 Pages: 59 - 63

10. Efficacy and Safety of Fluvastatin in Women with Primary Hypercholesterolemia

    • T. K. Peters
    • E. N. Muratti
    • M. Mehra

    OriginalPaper 18 October 2012 Pages: 64 - 72

11. Discussion: Section 3

    OriginalPaper 18 October 2012 Pages: 73 - 74

12. Round-Table Discussion

    OriginalPaper 18 October 2012 Pages: 75 - 76

13. Concluding Remarks

    OriginalPaper 18 October 2012 Pages: 77 - 77